Skip to main content
SpringerLink
Log in

Effect of combined deferasirox and 5-azacytidine treatment on human leukemia cells in vitro

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Adams RL, Bird RJ (2013) Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review. Ther Adv Hematol 4:93–102

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Garcia-Manero G (2014) Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol 89:97–108

    Article  CAS  PubMed  Google Scholar 

  3. Dong C, Zhang H, Xu C, Arrowsmith CH, Min J (2014) Structure and function of dioxygenases in histone demethylation and DNA/RNA demethylation. IUCrJ 1:540–549

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Torti SV, Torti FM (2013) Iron and cancer: more ore to be mined. Nat Rev Cancer 13:342–355

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Stresemann C, Lyko F (2008) Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer 123:8–13

    Article  CAS  PubMed  Google Scholar 

  6. Breccia M, Voso MT, Aloe Spiriti MA, Fenu S, Maurillo L, Buccisano F, Tafuri A, Alimena G (2015) An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms. Ann Hematol 94:771–777

    Article  CAS  PubMed  Google Scholar 

  7. Guariglia R, Martorelli MC, Villani O, Pietrantuono G, Mansueto G, D’Auria F, Grieco V, Bianchino G, Lerose R, Bochicchio GB, Musto P (2011) Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: a brief review. Leuk Res 35:566–570

    Article  PubMed  Google Scholar 

  8. Messa E, Cilloni D, Messa F, Arruga F, Roetto A, Saglio G (2008) Deferasirox treatment improved the hemoglobin level and decreased transfusion requirements in four patients with the myelodysplastic syndrome and primary myelofibrosis. Acta Haematol 120:70–74

    Article  CAS  PubMed  Google Scholar 

  9. Ohyashiki JH, Kobayashi C, Hamamura R, Okabe S, Tauchi T, Ohyashiki K (2009) The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1. Cancer Sci 100:970–977

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Private University Strategic Research-Based Support Project (S1311016) from the Ministry of Education, Culture, Sports, Science and Technology (Tokyo, Japan).

Conflict of interests

SI received honorarium for supervision from Nippon Shinyaku. J H.O received research support from Novartis KK. KO received research support from Celegene KK and Novartis Pharma KK, served as consultant and advisor of Celegene KK, and honoraria for lecture fees from Nippon Shinyaku and Novartis Pharma KK. RT and MO have no conflict of interests to disclose.

Author information

Authors and Affiliations

  1. Institute of Medical Science, Tokyo Medical University, 6-7-1 Nishishinjuku, Tokyo, 160-0023, Japan

    Satoshi Imanishi, Ryoko Takahashi, Miho Ohsuga & Junko H. Ohyashiki

  2. Department of Hematology, Tokyo Medical University, 6-7-1 Nishishinjuku, Tokyo, 160-0023, Japan

    Kazuma Ohyashiki

Authors
  1. Satoshi Imanishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryoko Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miho Ohsuga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuma Ohyashiki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Junko H. Ohyashiki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Satoshi Imanishi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Imanishi, S., Takahashi, R., Ohsuga, M. et al. Effect of combined deferasirox and 5-azacytidine treatment on human leukemia cells in vitro. Ann Hematol 94, 1601–1602 (2015). https://doi.org/10.1007/s00277-015-2417-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2417-9

Keywords

Search

Navigation